Overview

The marketing authorisation for TruScient has been withdrawn at the request of the marketing authorisation holder.

български (BG) (218.13 KB - PDF)

View

español (ES) (219.39 KB - PDF)

View

čeština (CS) (221.21 KB - PDF)

View

dansk (DA) (196.28 KB - PDF)

View

Deutsch (DE) (219.87 KB - PDF)

View

eesti keel (ET) (220.58 KB - PDF)

View

ελληνικά (EL) (223.98 KB - PDF)

View

français (FR) (220.78 KB - PDF)

View

italiano (IT) (218.46 KB - PDF)

View

latviešu valoda (LV) (216.78 KB - PDF)

View

lietuvių kalba (LT) (218.76 KB - PDF)

View

magyar (HU) (239.21 KB - PDF)

View

Malti (MT) (219.92 KB - PDF)

View

Nederlands (NL) (195.35 KB - PDF)

View

polski (PL) (222.4 KB - PDF)

View

português (PT) (196.44 KB - PDF)

View

română (RO) (219.8 KB - PDF)

View

slovenčina (SK) (242.89 KB - PDF)

View

slovenščina (SL) (233.64 KB - PDF)

View

Suomi (FI) (195.98 KB - PDF)

View

svenska (SV) (193.82 KB - PDF)

View

Product information

български (BG) (443.35 KB - PDF)

View

español (ES) (365.02 KB - PDF)

View

čeština (CS) (425.46 KB - PDF)

View

dansk (DA) (371.48 KB - PDF)

View

Deutsch (DE) (397.22 KB - PDF)

View

eesti keel (ET) (417.19 KB - PDF)

View

ελληνικά (EL) (464.42 KB - PDF)

View

français (FR) (425.36 KB - PDF)

View

íslenska (IS) (381.08 KB - PDF)

View

italiano (IT) (399.85 KB - PDF)

View

latviešu valoda (LV) (426.83 KB - PDF)

View

lietuvių kalba (LT) (428.56 KB - PDF)

View

magyar (HU) (436.37 KB - PDF)

View

Malti (MT) (483.67 KB - PDF)

View

Nederlands (NL) (410.73 KB - PDF)

View

norsk (NO) (390.32 KB - PDF)

View

polski (PL) (443.92 KB - PDF)

View

português (PT) (374.05 KB - PDF)

View

română (RO) (427.72 KB - PDF)

View

slovenčina (SK) (431.78 KB - PDF)

View

slovenščina (SL) (430.91 KB - PDF)

View

Suomi (FI) (391.15 KB - PDF)

View

svenska (SV) (396.36 KB - PDF)

View

Latest procedure affecting product information: IAIN/0005/G

15/01/2015

български (BG) (410.19 KB - PDF)

View

español (ES) (394.1 KB - PDF)

View

čeština (CS) (404.3 KB - PDF)

View

dansk (DA) (393.94 KB - PDF)

View

Deutsch (DE) (387.42 KB - PDF)

View

eesti keel (ET) (387.03 KB - PDF)

View

ελληνικά (EL) (407.02 KB - PDF)

View

français (FR) (386.86 KB - PDF)

View

íslenska (IS) (259.1 KB - PDF)

View

italiano (IT) (259.23 KB - PDF)

View

latviešu valoda (LV) (276.1 KB - PDF)

View

lietuvių kalba (LT) (267.12 KB - PDF)

View

magyar (HU) (272.45 KB - PDF)

View

Malti (MT) (275.42 KB - PDF)

View

Nederlands (NL) (259.53 KB - PDF)

View

norsk (NO) (263.99 KB - PDF)

View

polski (PL) (275.32 KB - PDF)

View

português (PT) (259.68 KB - PDF)

View

română (RO) (271.55 KB - PDF)

View

slovenčina (SK) (275.09 KB - PDF)

View

slovenščina (SL) (265.89 KB - PDF)

View

Suomi (FI) (393.53 KB - PDF)

View

svenska (SV) (263.95 KB - PDF)

View

Product details

Name of medicine
TruScient
Active substance
dibotermin alfa
International non-proprietary name (INN) or common name
dibotermin alfa
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QM05BC01

Pharmacotherapeutic group

Bone morphogenetic proteins

Therapeutic indication

Osteoinductive agent for use in the treatment of long-bone fractures as an adjunct to standard surgical care using open fracture reduction in dogs.

Authorisation details

EMA product number
EMEA/V/C/002000
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
14/12/2011
Revision
4

Assessment history

This page was last updated on

How useful do you find this page?